Jinyu Bio-technology announced that it expects net profit attributable to shareholders of the listed company for the first half of 2026 to be between 91 million yuan and 109 million yuan, representing a year-on-year increase of 50.60% to 80.39%. The profit growth was mainly driven by multiple factors, including substantial growth in the ruminant and pet animal health businesses, the emergence of synergies from industrial mergers and acquisitions, cost and expense optimization propelled by digital and lean management, and the launch of new products. The company's net profit for the first quarter was 81 million yuan, implying an expected quarter-on-quarter decline of 64% to 87% in net profit for the second quarter.
Jinyu Bio-Technology Co LtdCompany expects net profit to rise 50.60%–80.39% year-on-year for first half 2026.